Omada Health The stocks rose by more than 40% in their Nasdaq debut on Friday after the virtual Chronic Care Company rated their stock in the IPO for USD 19 per share.
The share opened $ 23 and quickly acted over $ 27.
In a press release on Thursday, the company said that it sold 7.9 million shares on offer, which corresponds to around $ 150 million. The pricing was in the middle of the expected area and estimated the company with a little more than 1 billion US dollars, although this number could be higher on a fully watered basis.
Omada, which was founded in 2012, deals under the ticker symbol “Omda”. The company offers virtual care programs to support patients with chronic diseases such as prediabetes, diabetes and high blood pressure. Sean Duffy, CEO of Omada, was a co -founder of the company with Andrew Dimichele and Adrian James, both of whom have passed to other activities.
More CNBC health insurance
It is the first public offer of digital health in a few weeks after an extensive drought for the industry. Startup health for digital physiotherapy in May on the New York Stock Exchange. Hain is currently at $ 38.50 after they have sold shares in the IPO at 32 USD.
The Tech -Po market showed signs of life, with the hinge being one of the latest offers. On Thursday shares of the crypto company Circle Internet 168% in the NYSE debut. The FinTech company Etoro started trading last month, and Chime Financial, which offers online banking services, will be launched next week.
“Today is the right moment for us,” Duffy told CNBCS “Squawk Box” on Friday. “We like the model's scale, we like the scale of the business, alike we felt from the capital markets.”
According to the prospectus, Omada's turnover rose by 57% in the first quarter to $ 55 million compared to $ 35.1 million in the previous year. For 2024, sales of $ 122.8 million increased by 38% to $ 169.8 million in the previous year. The company's lust for the net decreased in the first quarter to 9.4 million US dollars compared to $ 19 million a previous year.
Us Venture Partners, Andreessen Horowitz and Fidelitys FMR LLC are the largest external shareholders of the company, each of which has between 9% and 10% of shares.
Do not miss these findings from CNBC Pro
Comments are closed.